Prometheus Biosciences to Present at the 41st Annual J.P. Morgan Healthcare Conference
03.01.2023 - SAN DIEGO, Jan. 03, 2023 (GLOBE NEWSWIRE) - Prometheus Biosciences, Inc. (Nasdaq: RXDX), a clinical-stage biotechnology company pioneering a precision medicine approach for the discovery, development, and commercialization of novel therapeutic and ...